New findings reveal that rheumatoid arthritis (RA) disease activity significantly affects the severity of interstitial lung disease (ILD), both radiologically and physiologically, in patients with RA ...

RA-ILD significantly increases mortality, with a median survival of less than 3 years post-diagnosis. Key risk factors include male gender, older age, smoking, pulmonary comorbidities, rheumatoid ...

Please provide your email address to receive an email when new articles are posted on . Eight clusters of related biomarkers were significantly associated with RA-ILD. The biomarkers led to a greater ...

Patients with rheumatoid arthritis (RA) and RA-interstitial lung disease are at an increased risk of lung cancer, according to the results of a retrospective, matched cohort study. "Prior studies have ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ILD was more likely in patients with RA starting ...

In patients with rheumatoid arthritis (RA), age at the onset of RA, smoking exposure, and rheumatoid factor or anti-cyclic citrullinated peptide seropositivity were independently associated with the ...

Lung ultrasound is effective for detecting ILD in RA patients, with high sensitivity and moderate specificity. B-lines are a primary criterion for ILD diagnosis in LUS, indicating pulmonary ...

For asymptomatic rheumatoid arthritis (RA) patients, a new radiation-free screening protocol can identify suspected interstitial lung involvement (ILI), according to a study published online Nov. 23 ...

Patients with rheumatoid arthritis (RA) face increased risk for interstitial lung disease (ILD) and comorbidities appear to raise it further. This retrospective study sought to compare different ...

Analysis included 72,795 Veterans Health Administration patients with RA and 633,937 matched non-RA persons. HealthDay News — Rheumatoid arthritis (RA) is associated with a significantly increased ...

SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary ...